Literature DB >> 23142560

Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension.

Gerrina Ruiter1, Yeun Ying Wong, Frances S de Man, M Louis Handoko, Richard T Jaspers, Pieter E Postmus, Nico Westerhof, Hans W M Niessen, Willem J van der Laarse, Anton Vonk-Noordegraaf.   

Abstract

BACKGROUND: In pulmonary arterial hypertension (PAH), high right ventricular (RV) power output requires increased myocardial oxygen consumption. Oxygen supply, however, does not increase in proportion. It is unknown what cellular mechanisms underlie this lack of adaptation. We therefore determined oxygen supply parameters in RV tissue slices of deceased PAH patients and compared them with RV tissue of patients who died from left ventricular myocardial infarction (MI). Because autopsy tissue only reflects end-stage disease, rat models with stable and progressive pulmonary hypertension (PH) were studied as well.
METHODS: Myocardial tissue of 10 PAH and 10 MI patients was collected at autopsy. In rats, stable PH (n = 6) and progressive PH (n = 6) was induced by 40 or 60 mg/kg monocrotaline, respectively. Six rats were used as controls.
RESULTS: RV cardiomyocyte cross-sectional area was strongly increased in PAH compared with MI patients (p < 0.001), whereas capillary density decreased (p < 0.01). Rat data showed similar RV hypertrophy in stable and progressive PH, and RV capillary density was decreased in both (p < 0.01 and p < 0.0001 vs control rats, respectively). RV myoglobin protein content and functional concentration were reduced in both human and rat PH RVs. In rats, this results from a lack of increase in myoglobin mRNA transcription per cardiomyocyte nucleus.
CONCLUSIONS: All measured cellular oxygen supply parameters are decreased in the failing human and rat pulmonary hypertensive RV. In contrast to stable PH rats, compensatory adaptations do not occur in end-stage PAH, despite higher myocardial oxygen consumption.
Copyright © 2013 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142560     DOI: 10.1016/j.healun.2012.09.025

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  18 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

2.  The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload.

Authors:  Mariëlle C van de Veerdonk; Sophie A Dusoswa; J Tim Marcus; Harm-Jan Bogaard; Onno Spruijt; Taco Kind; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-04       Impact factor: 2.357

3.  Intrinsic cardiac adrenergic (ICA) cell density and MAO-A activity in failing rat hearts.

Authors:  Vincent W W van Eif; Sylvia J P Bogaards; Willem J van der Laarse
Journal:  J Muscle Res Cell Motil       Date:  2013-12-19       Impact factor: 2.698

4.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

Review 5.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

Review 6.  Pressure-overload-induced right heart failure.

Authors:  S Rain; M L Handoko; A Vonk Noordegraaf; H J Bogaard; J van der Velden; F S de Man
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

7.  Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions.

Authors:  Gregory J Bittle; David Morales; Kristopher B Deatrick; Nathaniel Parchment; Progyaparamita Saha; Rachana Mishra; Sudhish Sharma; Nicholas Pietris; Alexander Vasilenko; Casey Bor; Chetan Ambastha; Muthukumar Gunasekaran; Deqiang Li; Sunjay Kaushal
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

Review 8.  FDG PET imaging for identifying pulmonary hypertension and right heart failure.

Authors:  Ali Ahmadi; Hiroshi Ohira; Lisa M Mielniczuk
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

9.  Proteomic and Metabolomic Analyses of Right Ventricular Failure due to Pulmonary Arterial Hypertension.

Authors:  Xiaohan Qin; Chuxiang Lei; Li Yan; Haidan Sun; Xiaoyan Liu; Zhengguang Guo; Wei Sun; Xiaoxiao Guo; Quan Fang
Journal:  Front Mol Biosci       Date:  2022-07-05

Review 10.  State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series).

Authors:  Mariëlle C van de Veerdonk; J Tim Marcus; Harm-Jan Bogaard; Anton Vonk Noordegraaf
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.